Kenji Onda

163 Studley Rd
Heidelberg, VIC 3084, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Kampo Medicines Modulate Angiogenic, Antioxidant, and Inflammatory Pathways in Human Preclinical Models: Implications for Preeclampsia.

Kampo Medicines Modulate Angiogenic, Antioxidant, and Inflammatory Pathways in Human Preclinical Models: Implications for Preeclampsia.

Journal: Antioxidants (Basel, Switzerland)

Published: June 08, 2026

Comprehensive pharmacovigilance assessment of pairwise drug-drug interactions and acute pancreatitis in the FDA adverse event reporting system: focus on incretin-based drugs.

Comprehensive pharmacovigilance assessment of pairwise drug-drug interactions and acute pancreatitis in the FDA adverse event reporting system: focus on incretin-based drugs.

Journal: Frontiers in drug safety and regulation

Published: March 10, 2026

Drug-drug interactions between sex hormones and analgesics linked to thromboembolic events: an FDA adverse event reporting system analysis.

Drug-drug interactions between sex hormones and analgesics linked to thromboembolic events: an FDA adverse event reporting system analysis.

Journal: Frontiers in pharmacology

Published: January 19, 2026

Association of Hypoglycemic Agents with the Risk of Platinum-Based Chemotherapy-Induced Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus.

Association of Hypoglycemic Agents with the Risk of Platinum-Based Chemotherapy-Induced Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus.

Journal: Oncology

Published: September 10, 2025

Differences in Approved Doses and Drug Lag in Drugs Approved between 2012 and 2021: A Comparison between Japan and the U.S.

Differences in Approved Doses and Drug Lag in Drugs Approved between 2012 and 2021: A Comparison between Japan and the U.S.

Journal: Biological & pharmaceutical bulletin

Published: August 27, 2025

Potential impact of nicorandil on the pharmacodynamics of anti-angiogenic agents.

Potential impact of nicorandil on the pharmacodynamics of anti-angiogenic agents.

Journal: Scientific reports

Published: May 23, 2025

Translational Research on Pre-eclampsia with Existing Drugs Targeting Antioxidant Molecules

Translational Research on Pre-eclampsia with Existing Drugs Targeting Antioxidant Molecules

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: January 05, 2025

Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting system.

Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting system.

Journal: Frontiers in drug safety and regulation

Published: November 07, 2023

Cepharanthine synergistically promotes methylprednisolone pharmacodynamics against human peripheral blood mononuclear cells possibly via regulation of P-glycoprotein/glucocorticoid receptor translocation.

Cepharanthine synergistically promotes methylprednisolone pharmacodynamics against human peripheral blood mononuclear cells possibly via regulation of P-glycoprotein/glucocorticoid receptor translocation.

Journal: BMC complementary medicine and therapies

Published: October 18, 2023

Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use.

Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use.

Journal: BMC pharmacology & toxicology

Published: July 27, 2023

Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting system.

Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting system.

Journal: Frontiers in pharmacology

Published: August 29, 2022

Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease.

Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease.

Journal: International journal of molecular sciences

Published: July 28, 2022

Showing 1-12 of 52

Last Updated: 09/26/2026